UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

Breast cancer research and treatment, 2011-11, Vol.130 (2), p.449-455

2011

Volltextzugriff (PDF)

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system ?

Oncoimmunology, 2017-01, Vol.6 (12), p.e1315488-e1315488

2017

Volltextzugriff (PDF)

Circulating tumor cells detection has independent prognostic impact in high‐risk non‐muscle invasive bladder cancer

International journal of cancer, 2014-10, Vol.135 (8), p.1978-1982

2014

Volltextzugriff (PDF)

Circulating tumor cells isolation： the ＂post-EpCAM era

Chinese journal of cancer research, 2015-10, Vol.27 (5), p.461-470

2015

Volltextzugriff (PDF)

Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Frontiers in oncology, 2019-12, Vol.9, p.1414-1414

2019

Volltextzugriff (PDF)

Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy"

International journal of molecular sciences, 2017-06, Vol.18 (6), p.1308

2017

Volltextzugriff (PDF)

Significance of Circulating Tumor Cells in Soft Tissue Sarcoma

Analytical cellular pathology (Amsterdam), 2015-01, Vol.2015 (2015), p.1-5

2015

Volltextzugriff (PDF)

EpCAM-Expressing Circulating Tumor Cells in Colorectal Cancer

The International journal of biological markers, 2017-10, Vol.32 (4), p.415-420

2017

Volltextzugriff (PDF)

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer

Cells (Basel, Switzerland), 2023-04, Vol.12 (8), p.1172

2023

Volltextzugriff (PDF)

Coexistence of three EGFR mutations in an NSCLC patient: A brief report

The International journal of biological markers, 2018-11, Vol.33 (4), p.545-548

2018

Volltextzugriff (PDF)

Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells

Chinese journal of cancer research, 2015-10, Vol.27 (5), p.491-496

2015

Volltextzugriff (PDF)

Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma

Analytical cellular pathology (Amsterdam), 2018-01, Vol.2018 (2018), p.1-4

2018

Volltextzugriff (PDF)

Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data

PeerJ (San Francisco, CA), 2019-11, Vol.7, p.e7972-e7972, Article e7972

2019

Volltextzugriff (PDF)

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

Scientific reports, 2016-08, Vol.6 (1), p.31726-31726, Article 31726

2016

Volltextzugriff (PDF)

Survivin, bcl-2, bax, and bcl-X Gene Expression in Sentinel Lymph Nodes From Melanoma Patients

Journal of clinical oncology, 2003-01, Vol.21 (2), p.306-312

2003

Volltextzugriff (PDF)

Circulating Tumor Cells Identify Patients with Super‐High‐Risk Non‐Muscle‐Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single‐Center Trial

The oncologist (Dayton, Ohio), 2019-05, Vol.24 (5), p.612-616

2019

Volltextzugriff (PDF)

Circulating tumor cells count and characterization in a male breast cancer patient

Cancer biology & therapy, 2011-09, Vol.12 (5), p.379-382

2011

Volltextzugriff (PDF)

Erythropoietin expression in primary rat Sertoli and peritubular myoid cells

Blood, 2001-11, Vol.98 (9), p.2872-2874

2001

Volltextzugriff (PDF)

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer

Cancers, 2019-01, Vol.11 (1), p.42

2019

Volltextzugriff (PDF)

Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer

Anti-cancer drugs, 2007-02, Vol.18 (2), p.179-185

2007

Volltextzugriff (PDF)

Circulating Tumor Cells: Gold in the Waste

Disease markers, 2019-09, Vol.2019

2019

Volltextzugriff (PDF)

EpCAM low Circulating Tumor Cells: Gold in the Waste

Disease markers, 2019-09, Vol.2019, p.1-5

2019

Volltextzugriff (PDF)

The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)

Journal of cancer research and clinical oncology, 2017-10, Vol.143 (10), p.1971-1976

2017

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(72)
Humans
(62)
Oncology
(47)
Biological And Medical Sciences
(28)
Female
(26)
Prognosis
(26)
Medical Sciences
(24)
Circulating Tumor Cells
(23)
Tumors
(23)
Male
(22)
Middle Aged
(19)
Aged
(17)
Neoplastic Cells, Circulating - Pathology
(17)
Adult
(14)
Reverse Transcriptase Polymerase Chain Reaction
(14)
Colorectal Cancer
(13)
Metastasis
(13)
Neoplastic Cells, Circulating - Metabolism
(13)
Nephrology. Urinary Tract Diseases
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system ?

Circulating tumor cells detection has independent prognostic impact in high‐risk non‐muscle invasive bladder cancer

Circulating tumor cells isolation： the ＂post-EpCAM era

Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy"

Significance of Circulating Tumor Cells in Soft Tissue Sarcoma

EpCAM-Expressing Circulating Tumor Cells in Colorectal Cancer

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer

Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method

Coexistence of three EGFR mutations in an NSCLC patient: A brief report

Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells

Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma

Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

Survivin, bcl-2, bax, and bcl-X Gene Expression in Sentinel Lymph Nodes From Melanoma Patients

Circulating Tumor Cells Identify Patients with Super‐High‐Risk Non‐Muscle‐Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single‐Center Trial

Circulating tumor cells count and characterization in a male breast cancer patient

Erythropoietin expression in primary rat Sertoli and peritubular myoid cells

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer

Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer

Circulating Tumor Cells: Gold in the Waste

EpCAM low Circulating Tumor Cells: Gold in the Waste

The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)

Suchergebnisse filtern